This article has been cited by
1Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer
Jan Kroon,Sander Kooijman,Nam-Joon Cho,Gert Storm,Gabri van der Pluijm
Trends in Pharmacological Sciences.2016;37(6)451
[DOI]
2Targeting persistent androgen receptor signaling in castration-resistant prostate cancer
Laura Graham,Michael T. Schweizer
Medical Oncology.2016;33(5)451
[DOI]
3Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
Nikolai A. Ognerubov
Journal of Modern Oncology.2021;23(3)477
[DOI]
4Design of a Small-Molecule Drug Conjugate for Prostate Cancer Targeted Theranostics
Amit Kumar,Tara Mastren,Bin Wang,Jer-Tsong Hsieh,Guiyang Hao,Xiankai Sun
Bioconjugate Chemistry.2016;27(7)1681
[DOI]
5Design of a Small-Molecule Drug Conjugate for Prostate Cancer Targeted Theranostics
Giovanni Luca Ceresoli,Maria Bonomi,Maria Grazia Sauta
Bioconjugate Chemistry.2017;27(7)121
[DOI]
6Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors
Nils Goehringer,Bernhard Biersack,Yayi Peng,Rainer Schobert,Marco Herling,Andi Ma,Bianca Nitzsche,Michael Höpfner
International Journal of Molecular Sciences.2021;22(16)8432
[DOI]
7Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes
Leslimar Ríos-Colón,Christina K. Cajigas-Du Ross,Anamika Basu,Catherine Elix,Ivana Alicea-Polanco,Tino W. Sanchez,Vinodh Radhakrishnan,Chien-Shing Chen,Carlos A. Casiano
Oncotarget.2017;8(15)24915
[DOI]
8Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m2) and the Currently Approved Dose (25 mg/m2) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer—PROSELICA
Mario Eisenberger,Anne-Claire Hardy-Bessard,Choung Soo Kim,Lajos Géczi,Daniel Ford,Loďc Mourey,Joan Carles,Phillip Parente,Albert Font,Gabriel Kacso,Mustapha Chadjaa,Wenping Zhang,John Bernard,Johann de Bono
Journal of Clinical Oncology.2017;35(28)3198
[DOI]
9Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer
Alexander S. Carlson,Rigo I. Acevedo,Daniel M. Lim,Roman Gulati,Agnes Gawne,Alexandra O. Sokolova,Heather H. Cheng,Peter S. Nelson,R. Bruce Montgomery,Evan Y. Yu,Michael T. Schweizer,Alvaro Galli
PLOS ONE.2020;15(9)e0239686
[DOI]
Feedback

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal